Harvard Bioscience Financial Market Data
| Last Close 18-Aug-2008 |
$4.75 |
Price/ Sales Ratio |
1.64 |
| 52-Week High |
$5.20 |
Price/ Book Ratio |
1.85 |
| 52-Week Low |
$3.62 |
Price/ Earnings Ratio |
-- |
| 60-Month Beta |
0.8 |
Price/ Cash Flow Ratio |
12.98 |
| Market Cap (mil.) |
$147.5 |
Return on Assets |
(1.3%) |
| Shares Outstanding (mil.) |
31.1 |
Return on Equity |
(1.6%) |
| Dividend Rate |
-- |
Current Ratio |
3.29 |
| Dividend Yield |
-- |
Long-Term Debt/Equity |
-- |
| # of Institutional Holders |
58 |
% Owned by Institutions |
81.0% |
| Latest Short Interest Ratio |
13.72 |
Latest Net Insider Transactions |
-- |
| Revenue Growth |
10.7% |
(7.1%) |
32.9% |
| EPS Growth |
0.0% |
0.0% |
0.0% |
| Dividend Growth |
0.0% |
0.0% |
0.0% |
This data is provided as per license from EDGAR Online
